BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18248833)

  • 1. [How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?].
    Azria D; Ozsahin M; Gligorov J; Zaman K; Llacer Moscardo C; Lemanski C; Jacot W; Belkacémi Y
    Cancer Radiother; 2008 Jan; 12(1):37-41. PubMed ID: 18248833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
    Azria D; Lemanski C; Zouhair A; Gutowski M; Belkacémi Y; Dubois JB; Romieu G; Ozsahin M
    Cancer Radiother; 2004 Jun; 8(3):188-96. PubMed ID: 15217586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant breast cancer treatment with hormono-radiotherapy].
    Azria D; Jacot W; Gligorov J; Belkacémi Y; Zaman K; Romieu G; Ozsahin M
    Bull Cancer; 2009 Mar; 96(3):285-9. PubMed ID: 19318306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in adjuvant endocrine therapy for postmenopausal women.
    Lin NU; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):798-805. PubMed ID: 18258989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current controversies in extended adjuvant endocrine therapy for early breast cancer.
    Snoj N; Paridaens R; Cufer T
    Curr Opin Oncol; 2008 Nov; 20(6):627-33. PubMed ID: 18841043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining systemic therapies with radiation in breast cancer.
    Adamowicz K; Marczewska M; Jassem J
    Cancer Treat Rev; 2009 Aug; 35(5):409-16. PubMed ID: 19464806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M; Yamashiro H; Tsuji W
    Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer].
    Hoeller U; Borgmann K; Feyer P; Souchon R;
    Strahlenther Onkol; 2007 Oct; 183(10):535-44. PubMed ID: 17896084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R
    Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen in breast cancer: not so easy to write off.
    Munshi A; Singh P
    Breast; 2008 Apr; 17(2):121-4. PubMed ID: 17923407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current adjuvant endocrine treatment of breast cancer].
    Dedes KJ; Gabriel N; Fink D
    Gynakol Geburtshilfliche Rundsch; 2008; 48(3):130-7. PubMed ID: 18566529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors predicting failure of adjuvant hormonotherapy of breast carcinoma. A study in tamoxifen treated patients].
    Petráková K; Nenutil R; Grell P; Fabian P; Zichová I; Svoboda M; Palácová M; Vyzula R
    Klin Onkol; 2008; 21(5):303-8. PubMed ID: 19202962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the benefits of adjuvant therapy in early HR+ breast cancer.
    Goss PE
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():45-52. PubMed ID: 18785006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 18. Translating trial data into patients benefits: making the right choice.
    Chlebowski RT
    Breast; 2008 Apr; 17 Suppl 3():S9-15. PubMed ID: 18367397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating elderly patients with hormone sensitive breast cancer: what do the data show?
    Balducci L
    Cancer Treat Rev; 2009 Feb; 35(1):47-56. PubMed ID: 18840391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal therapy in breast cancer].
    Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
    Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.